Lamin B. Jarju

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Micron Biomedical (United States)(Current)

Lamin B. Jarju is an author at Micron Biomedical (United States) specializing in vaccine clinical trial design, infectious diseases, and thermostability.

Publications per year

2022–2022

Publications

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]

Ikechukwu Adigweme, Edem Akpalu, Mohammed Nakodi Yisa et al. · Trials · 2022 · 25 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

1–1 of 1